New inhaled COVID-19 vaccine by McMaster enters phase-2 trials in Canada. The vaccine aims to provide stronger, needle-free ...

Vaxxas, a clinical-stage biotechnology company, today announced it has secured a new patent from the United States patent office covering proprietary manufacturing technology for its novel vaccination ...

One avenue for new vaccine development is mucosal vaccines. In theory, dosing the vaccine directly into the respiratory tract ...

Vaxxas, a clinical-stage biotechnology company, today announced it has secured a new patent from the United States patent office covering proprietary manufacturing technology for its novel ...

Since the onset of the COVID-19 pandemic, vaccination rates for both children and adults have declined. Public trust in ...

Researchers at McMaster University have started a phase-2 clinical trial on a next-generation, inhaled COVID-19 vaccine.

But some patients are afraid of the needle. Exploring alternative vaccine delivery systems could increase accessibility and encourage those who fear needles to receive necessary healthcare. While ...

Public opinion about vaccines affects furry friends too. We asked veterinarians and other experts to explain the most common misconceptions about animal vaccines.

Researchers at McMaster University have started a phase-2 clinical trial on a next-generation, inhaled COVID-19 vaccine.